NMXS (Net Medical Xpress Solutions) ROCE %: 14.87% (As of Jun. 2018)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Net Medical Xpress Solutions ROCE %?

Net Medical Xpress Solutions NMXS +0.14% ROCE % is 14.87% as of Jun. 2018.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Net Medical Xpress Solutions's annualized ROCE % for the quarter that ended in Jun. 2018 was 14.87%.

Net Medical Xpress Solutions  (OTCPK:NMXS) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Net Medical Xpress Solutions ROCE % Related Terms

Net Medical Xpress Solutions ROCE % Historical Data

* Premium members only.

The historical data trend for Net Medical Xpress Solutions's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Net Medical Xpress Solutions ROCE % Chart

Net Medical Xpress Solutions Annual Data
Trend Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 33.66 12.03 -102.98 35.05 -70.90

Net Medical Xpress Solutions Quarterly Data
Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Mar18 Jun18
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -46.64 -89.05 -92.44 -94.98 14.87

Net Medical Xpress Solutions ROCE % Calculation

Net Medical Xpress Solutions's annualized ROCE % for the fiscal year that ended in Dec. 2016 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2016 )  (A: Dec. 2015 )(A: Dec. 2016 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2016 )  (A: Dec. 2015 )(A: Dec. 2016 )
=-0.335/( ( (1.201 - 0.609) + (0.82 - 0.467) )/ 2 )
=-0.335/( (0.592+0.353)/ 2 )
=-0.335/0.4725
=-70.90 %

Net Medical Xpress Solutions's ROCE % of for the quarter that ended in Jun. 2018 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Jun. 2018 )  (Q: Mar. 2018 )(Q: Jun. 2018 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Jun. 2018 )  (Q: Mar. 2018 )(Q: Jun. 2018 )
=0.06/( ( (0.73 - 0.332) + (0.816 - 0.407) )/ 2 )
=0.06/( ( 0.398 + 0.409 )/ 2 )
=0.06/0.4035
=14.87 %

(1) Note: The EBIT data used here is four times the quarterly (Jun. 2018) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 14.87% mean?
Net Medical Xpress Solutions (NMXS) has a ROCE % of 14.87% as of Jun. 2018.
Is Net Medical Xpress Solutions' ROCE % too high?
Net Medical Xpress Solutions' current ROCE % is 14.87%. The Healthcare Providers & Services industry median ROCE % is 6.51. Net Medical Xpress Solutions' value of 14.87% is 128.4% above this industry median.
How does Net Medical Xpress Solutions' ROCE % compare to TVMD and UCBB?
Net Medical Xpress Solutions' ROCE % of 14.87% can be compared against companies in the Healthcare Providers & Services industry. The industry median ROCE % is 6.51. Net Medical Xpress Solutions' value of 14.87% is 128.4% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Healthcare Providers & Services company?
The median ROCE % among Healthcare Providers & Services companies is 6.51, based on 641 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Net Medical Xpress Solutions's current ROCE % of 14.87% is 128.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median ROCE % is 6.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Net Medical Xpress Solutions's current ROCE % is 14.87%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Net Medical Xpress Solutions stock overvalued right now?
Net Medical Xpress Solutions (NMXS) has a current ROCE % of 14.87%. The current ROCE % is 14.87% and 128.4% above the Healthcare Providers & Services industry median of 6.51. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Net Medical Xpress Solutions (NMXS), the current ROCE % is 14.87% as of Jun. 2018. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Net Medical Xpress Solutions Business Description

Address 8206 Louisiana Boulevard NE, Suite A, Albuquerque, NM, USA, 87113
Net Medical Xpress Solutions Inc is engaged in providing solutions to the telemedicine industry which deliver medical laboratory services. It offers proprietary software that links electronic medical records while enabling state-of-the-art conferencing and communications. The company's mobile fleet of vans is utilized to provide sales support for its clinical research organization. It also offers call centers, proprietary hardware implementations, diagnostic and clinical services, and software research and development capabilities.